• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results

    6/4/24 12:00:38 PM ET
    $ANNX
    $BBWI
    $DBI
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $ANNX alert in real time by email

    U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 50 points on Tuesday.

    The Dow traded down 0.14% to 38,516.73 while the NASDAQ fell 0.38% to 16,764.41. The S&P 500 also fell, dropping, 0.39% to 5,262.91.

    Check This Out: Top 3 Financial Stocks You’ll Regret Missing This Quarter

    Leading and Lagging Sectors

    Real estate shares rose by 0.8% on Tuesday.

    In trading on Tuesday, energy shares fell by 1.7%.

    Top Headline

    Shares of Bath & Body Works Inc (NYSE:BBWI) fell around 10% during Tuesday's session after the company reported results for its first quarter.

    Bath & Body Works reported a first-quarter FY24 sales decline of 0.9% year-on-year to $1.38 billion, beating the analyst consensus estimate of $1.36 billion. Adjusted EPS of 38 cents beat the analyst consensus estimate of 32 cents.

    Bath & Body Works narrowed FY24 EPS guidance to $3.05-$3.35 (prior $3.00 – $3.35)  versus the consensus of $3.31. The company also narrowed its FY24 sales outlook to decline of 2.5% – 0% (prior decline of 3% – 0%).

    The company said it sees second-quarter sales to decline 2% – flat and sees EPS of $0.31 – $0.36, versus the consensus estimate of $0.39.

    Equities Trading UP
                           

    • MicroAlgo Inc (NASDAQ:MLGO) shares shot up 365% to $7.26 after the company announced that it will jointly establish a micro-consciousness quantum research center with WiMi.
    • Shares of Sobr Safe Inc (NASDAQ:SOBR) got a boost, surging 140% to $0.63 after the company announced SOBRsure device purchases from two new customers.
    • Annexon, Inc. (NASDAQ:ANNX) shares were also up, gaining 28% to $5.85 after the company’s Phase 3 trial of ANX005 met its primary endpoint.

    Equities Trading DOWN

    • ENDRA Life Sciences Inc (NASDAQ:NDRA) shares dropped 66% to $0.074 after the company announced pricing of $8.0 million public offering.
    • Shares of Equillium Inc (NASDAQ:EQ) were down 22% to $1.14 after the company announced topline data from its Phase 2 study of EQ101 in alopecia areata.
    • Designer Brands Inc (NYSE:DBI) was down, falling 18% to $9.03 following first-quarter earnings.

    Also Check This Out: Wall Street’s Most Accurate Analysts’ Views On 3 Utilities Stocks With Over 4% Dividend Yields

    Commodities

    In commodity news, oil traded down 1.7% to $72.96 while gold traded down 1% at $2,346.30.

    Silver traded down 3.5% to $29.715 on Tuesday, while copper fell 2.4% to $4.5540.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.25%, Germany's DAX dipped 0.54% and France's CAC 40 fell 0.29%. Spain's IBEX 35 Index declined 0.54%, while London's FTSE 100 fell 0.21%.

    German jobless rate came in unchanged at 5.9% for the sixth straight month in May. Retail sales in the UK gained 0.4% from a year ago in May following a 4.4% decline in the prior month.

    Asia Pacific Markets

    Asian markets closed mixed on Tuesday, with Japan's Nikkei falling 0.22%, China's Composite Index gaining 0.14%, Hong Kong's Hang Seng Index climbing 0.22% and India's S&P BSE Sensex dipping 5.74%.

    Australia reported a current account deficit of AUD 4.9 billion in the first quarter, versus a revised surplus of AUD 2.7 billion in the fourth quarter. Retail sales in Australia increased by 0.1% month-over-month in April compared to a 0.4% decline in the previous period.

    Economics

    • The Logistics Manager's Index rose to 55.6 in May from a reading of 52.9 in April.
    • The RealClearMarkets/TIPP Economic Optimism Index declined to 40.5 in June compared to 41.8 in May.
    • U.S. factory orders increased by 0.7% from the prior month to $588.2 billion in April.
    • The number of job openings fell by 296,000 from the prior month to 8.059 million for April.

    Now Read This: Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $ANNX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANNX
    $BBWI
    $DBI
    $EQ

    CompanyDatePrice TargetRatingAnalyst
    Bath & Body Works Inc.
    $BBWI
    2/27/2026$17.00 → $23.00Market Perform
    Telsey Advisory Group
    Equillium Inc.
    $EQ
    2/25/2026$5.00Buy
    Stifel
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Bath & Body Works Inc.
    $BBWI
    1/14/2026$24.00Hold
    Jefferies
    Bath & Body Works Inc.
    $BBWI
    1/8/2026$21.00Buy → Hold
    Deutsche Bank
    Annexon Inc.
    $ANNX
    12/23/2025$16.00Buy
    Chardan Capital Markets
    Bath & Body Works Inc.
    $BBWI
    12/10/2025Neutral
    Guggenheim
    Bath & Body Works Inc.
    $BBWI
    11/21/2025$19.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ANNX
    $BBWI
    $DBI
    $EQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Bath & Body Works with a new price target

    Telsey Advisory Group reiterated coverage of Bath & Body Works with a rating of Market Perform and set a new price target of $23.00 from $17.00 previously

    2/27/26 8:06:42 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Stifel initiated coverage on Equillium with a new price target

    Stifel initiated coverage of Equillium with a rating of Buy and set a new price target of $5.00

    2/25/26 7:52:10 AM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ANNX
    $BBWI
    $DBI
    $EQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $20,657 worth of shares (4,115 units at $5.02), increasing direct ownership by 8% to 54,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    1/2/26 4:30:06 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Carson William H. bought $18,394 worth of shares (4,115 units at $4.47), increasing direct ownership by 9% to 50,290 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    12/3/25 4:30:14 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Choi Jung bought $138,270 worth of shares (33,000 units at $4.19) (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    12/3/25 4:30:20 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $BBWI
    $DBI
    $EQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bath & Body Works Hops Into Spring With Joy-Filled PEEPS® Collaboration

     What to know:  Bath & Body Works is launching a limited-time PEEPS® collaboration for spring and Easter. The joyful, nostalgia-driven collection brings the iconic Marshmallow treat to life across body care, home fragrance, décor and accessories. The collection features a marshmallow gourmand fragrance, Peepin' It Real. Developed with world-class perfumers, the scent blends fluffy marshmallow, sugar crystals and whipped vanilla to deliver a true-to-life, crave-worthy fragrance experience inspired by PEEPS®. The collection will be available to Bath & Body Works loyalty members online beginning Sunday, March 1, and to all consumers Monday, March 2 in stores and online across the U.S. and Cana

    2/27/26 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

    Achieved Intraclass Correlation Coefficient (ICC) of 0.89 with standard error of measurement (SEM) of 3.3% using independent operators ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced favorable results from a clinical study evaluating the measurement consistency of its TAEUS® Liver device. The study demonstrated the device's robust intra-user repeatability and inter-user reproducibility, essential factors for long-term monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), which now affects approximately 30% of ad

    2/26/26 8:00:00 AM ET
    $NDRA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

    LA JOLLA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026 at 10:40am ET. Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference. About EquilliumEquillium is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders. The company's lead therapeutic candidate is EQ504, a po

    2/25/26 8:30:00 AM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $BBWI
    $DBI
    $EQ
    SEC Filings

    View All

    SEC Form S-8 filed by SOBR Safe Inc.

    S-8 - SOBR Safe, Inc. (0001425627) (Filer)

    2/27/26 5:14:59 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form 8-K filed by Bath & Body Works Inc.

    8-K - Bath & Body Works, Inc. (0000701985) (Filer)

    2/25/26 5:04:38 PM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 144 filed by Annexon Inc.

    144 - Annexon, Inc. (0001528115) (Subject)

    2/18/26 3:39:19 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $BBWI
    $DBI
    $EQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Toal Sheamus

    3 - Designer Brands Inc. (0001319947) (Issuer)

    2/24/26 10:22:32 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 4 filed by PRESIDENT AND CEO Love Douglas

    4 - Annexon, Inc. (0001528115) (Issuer)

    2/23/26 7:11:22 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHIEF MEDICAL OFFICER Dananberg Jamie was granted 56,250 shares, increasing direct ownership by 77% to 129,402 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    2/23/26 7:09:58 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $BBWI
    $DBI
    $EQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Designer Brands Inc.

    SC 13G/A - Designer Brands Inc. (0001319947) (Subject)

    12/12/24 6:00:14 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Equillium Inc.

    SC 13G/A - Equillium, Inc. (0001746466) (Subject)

    11/14/24 9:50:36 PM ET
    $EQ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Annexon Inc.

    SC 13G/A - Annexon, Inc. (0001528115) (Subject)

    11/14/24 7:21:59 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANNX
    $BBWI
    $DBI
    $EQ
    Leadership Updates

    Live Leadership Updates

    View All

    Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer

    Appointment Effective February 16, 2026 COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), today announced that Sheamus Toal will join the company as Executive Vice President, Chief Financial Officer and Principal Financial Officer, effective February 16, 2026. Mark Haley, who has served as Interim Principal Financial Officer during the transition period, will return full time to his position as Senior Vice President, Controller and Principal Accounting Officer. Sheamus brings deep financial

    2/11/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Bath & Body Works Outlines Strategic Transformation for Sustainable Growth and Reports 2025 Third Quarter Results

    Launches the Consumer First Formula with four strategic priorities to drive sustainable long-term growthThird-quarter net sales of $1.6 billion, down 1%. Earnings per diluted share of $0.37; Adjusted earnings per diluted share of $0.35Q4 and full-year 2025 guidance lowered reflecting current business trends and continuation of recent macro consumer pressures COLUMBUS, Ohio, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) today reported third quarter 2025 results. Daniel Heaf, chief executive officer of Bath & Body Works, commented, "Today, we are excited to announce a comprehensive transformation plan to revitalize Bath & Body Works across brand, product, and market

    11/20/25 6:55:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Bath & Body Works Announces Key Leadership Appointments

    Maly Bernstein appointed Chief Commercial Officer to Strengthen Engagement and Performance Across All Channels Samantha Charleston appointed Chief Human Resources Officer to Align People Strategy with Business Priorities  COLUMBUS, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) today announced strategic leadership appointments to deepen expertise and strengthen capabilities required to execute transformation. Maly Bernstein has been appointed Chief Commercial Officer and Samantha Charleston has been appointed Chief Human Resources Officer, both effective Nov. 12.  "As we enter a new era for Bath & Body Works, we're building a next-generation leadership team w

    11/4/25 9:00:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ANNX
    $BBWI
    $DBI
    $EQ
    Financials

    Live finance-specific insights

    View All

    Bath & Body Works to Report Fourth Quarter and Fiscal 2025 Results on March 4, 2026

    COLUMBUS, Ohio, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today that it plans to report its fourth quarter and fiscal 2025 financial results before market open on Wednesday, March 4, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Eva Boratto, chief financial officer, will discuss the company's results and provide a business update. Supplemental materials will be posted approximately 90 minutes prior to the start of the conference call on the events and presentations page in the Investors section of the company's website at bbwinc.com. Investors and a

    2/18/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Bath & Body Works Declares Cash Dividend

    COLUMBUS, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE:BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on March 6, 2026, to shareholders of record at the close of business on February 20, 2026. ABOUT BATH & BODY WORKS: Home of America's Favorite Fragrances®, Bath & Body Works is a global leader in personal care and home fragrance, including top-selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Powered by agility and innovation, the company's predominantly U.S.-based supply chain enables it to deliver quality, on-trend luxuries a

    2/6/26 8:30:00 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Designer Brands Inc. Reports Third Quarter 2025 Financial Results

    Generated diluted earnings per share ("EPS") of $0.35 and adjusted diluted EPS of $0.38, both up over 40% compared to the same period last year Delivered 210-basis point improvement in gross margin over the same period last year Fiscal 2025 adjusted operating income expected to be in range of $50.0 million to $55.0 million COLUMBUS, Ohio, Dec. 9, 2025 /PRNewswire/ -- Designer Brands Inc. (NYSE: DBI) (the "Company," "we," "us," "our," and "Designer Brands"), one of the world's largest designers, producers, and retailers of footwear and accessories, today announced financial results for the third quarter ended November 1, 2025.

    12/9/25 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary